Catalyst Calendar
Scope

Tue, Jun 2, 2026

1 updates
PROK
8:00 AM

ProKidney Appoints Kenneth Locke as Chief Technical Officer

Kenneth Locke joins as Chief Technical Officer, bringing more than 25 years of experience across Chemistry, Manufacturing and Controls (CMC) and Supply Chain as ProKidney progresses toward the potential commercialization of rilparencel WINSTON-SALEM, N.C., June 02, 2026 (GLOBE NEWSWIRE) --

prokidney.com

Fri, May 15, 2026

1 updates
PROK
11:45 AM

ProKidney Reports First Quarter 2026 Financial Results and Business Highlights

On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate pivotal topline results in Q2 2027 Peer-reviewed results from the Phase 2 REGEN-007 study were published in the Clinical Journal of the American Society of Nephrology

Enrollment • Phase 3Enrollment completion Tue, Jun 30, 2026prokidney.com